microRNA information: hsa-miR-708-3p
Section | ID | link |
---|---|---|
Mature name: | hsa-miR-708-3p | miRbase |
Accession: | MIMAT0004927 | miRbase |
Precursor name: | hsa-mir-708 | miRbase |
Precursor accession: | MI0005543 | miRbase |
Symbol: | MIR708 | HGNC |
RefSeq ID: | NR_030598 | GenBank |
Sequence: | CAACUAGACUGUGAGCUUCUAG |
Reported expression in cancers: hsa-miR-708-3p
miRNA | cancer | regulation | reporting | PUBMED | method |
---|---|---|---|---|---|
hsa-miR-708-3p | colorectal cancer | upregulation | "miR-708 and miR-31 were found to be highly express ......" | 25202407 | |
hsa-miR-708-3p | liver cancer | downregulation | "MicroRNA 708 is downregulated in hepatocellular ca ......" | 26211597 | Reverse transcription PCR; qPCR |
hsa-miR-708-3p | lung cancer | upregulation | "Increased miR 708 expression in NSCLC and its asso ......" | 22573352 | |
hsa-miR-708-3p | lymphoma | deregulation | "We identified an miRNA signature of 7 miRNAs 5 upr ......" | 23801630 | |
hsa-miR-708-3p | prostate cancer | downregulation | "By microarray approach we identified seven miRNAs ......" | 26831660 | Microarray; qPCR |
Reported cancer pathway affected by hsa-miR-708-3p
miRNA | cancer | pathway | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-708-3p | bladder cancer | Apoptosis pathway | "Bladder cancer cell lines were exposed to normoxic ......" | 26196183 | Flow cytometry |
hsa-miR-708-3p | colorectal cancer | Apoptosis pathway | "Regulatory roles of microRNA 708 and microRNA 31 i ......" | 25202407 | |
hsa-miR-708-3p | glioblastoma | Apoptosis pathway | "miR 708 acts as a tumor suppressor in human gliobl ......" | 23754151 | |
hsa-miR-708-3p | prostate cancer | Apoptosis pathway | "Metformin induces ER stress dependent apoptosis th ......" | 26075749 |
Reported cancer prognosis affected by hsa-miR-708-3p
miRNA | cancer | prognosis | reporting | PUBMED | functional study |
---|---|---|---|---|---|
hsa-miR-708-3p | liver cancer | progression; tumorigenesis; staging; metastasis | "MicroRNA 708 is downregulated in hepatocellular ca ......" | 26211597 | |
hsa-miR-708-3p | lung cancer | poor survival; staging | "Increased miR 708 expression in NSCLC and its asso ......" | 22573352 | |
hsa-miR-708-3p | lung squamous cell cancer | staging | "This study contained three phases: 1 marker discov ......" | 20526284 | |
hsa-miR-708-3p | ovarian cancer | metastasis; cell migration; poor survival | "Glucocorticoids mediate induction of microRNA 708 ......" | 25569036 | |
hsa-miR-708-3p | prostate cancer | worse prognosis; progression; poor survival; recurrence | "In this study we report that miR-708 is a key nega ......" | 22552290 |
Reported gene related to hsa-miR-708-3p
miRNA | cancer | gene | reporting | PUBMED |
---|---|---|---|---|
hsa-miR-708-3p | prostate cancer | AKT2 | "Together our findings suggest that reduced miR-708 ......" | 22552290 |
hsa-miR-708-3p | prostate cancer | CD44 | "Together our findings suggest that reduced miR-708 ......" | 22552290 |
hsa-miR-708-3p | colorectal cancer | CDKN2B | "In addition the CDKN2B protein levels were signifi ......" | 25202407 |
hsa-miR-708-3p | breast cancer | KDM1A | "miR-708 could directly target the LSD1 3'UTR to do ......" | 26833707 |
hsa-miR-708-3p | ovarian cancer | RAP1B | "Glucocorticoids mediate induction of microRNA 708 ......" | 25569036 |
hsa-miR-708-3p | lung cancer | TMEM88 | "The transcript for TMEM88 gene has a miR-708 bindi ......" | 22573352 |
Expression profile in cancer corhorts:
Putative target regulations
miRNA | Gene | Cancer | Interaction | Correlation beta |
---|---|---|---|---|
hsa-miR-708-3p | MPL | 10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD | miRNAWalker2 validate; miRTarBase | TCGA BLCA -0.086; TCGA BRCA -0.111; TCGA CESC -0.079; TCGA ESCA -0.122; TCGA HNSC -0.171; TCGA KIRC -0.081; TCGA LUAD -0.127; TCGA LUSC -0.149; TCGA PAAD -0.185; TCGA PRAD -0.17 |
hsa-miR-708-3p | HLF | 10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.366; TCGA BRCA -0.169; TCGA HNSC -0.346; TCGA KIRC -0.172; TCGA LGG -0.14; TCGA LUAD -0.374; TCGA PRAD -0.325; TCGA THCA -0.164; TCGA STAD -0.303; TCGA UCEC -0.281 |
hsa-miR-708-3p | REEP1 | 9 cancers: BLCA; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD | MirTarget | TCGA BLCA -0.295; TCGA LGG -0.305; TCGA LUAD -0.289; TCGA LUSC -0.187; TCGA PAAD -0.247; TCGA PRAD -0.276; TCGA SARC -0.226; TCGA THCA -0.117; TCGA STAD -0.332 |
hsa-miR-708-3p | CPEB3 | 11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; UCEC | MirTarget; miRNATAP | TCGA BLCA -0.141; TCGA BRCA -0.183; TCGA ESCA -0.073; TCGA HNSC -0.287; TCGA KIRC -0.152; TCGA LGG -0.106; TCGA LUAD -0.132; TCGA LUSC -0.185; TCGA PAAD -0.125; TCGA PRAD -0.163; TCGA UCEC -0.099 |
hsa-miR-708-3p | CAPZA2 | 10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; UCEC | MirTarget | TCGA BLCA -0.086; TCGA COAD -0.115; TCGA ESCA -0.084; TCGA HNSC -0.079; TCGA KIRP -0.105; TCGA LUAD -0.082; TCGA LUSC -0.111; TCGA PRAD -0.106; TCGA SARC -0.072; TCGA UCEC -0.081 |
hsa-miR-708-3p | PPP1R15B | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PRAD; STAD | MirTarget | TCGA BLCA -0.06; TCGA CESC -0.06; TCGA COAD -0.119; TCGA ESCA -0.078; TCGA HNSC -0.063; TCGA KIRC -0.057; TCGA LGG -0.073; TCGA LUSC -0.089; TCGA PRAD -0.061; TCGA STAD -0.056 |
hsa-miR-708-3p | SLC25A46 | 9 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.05; TCGA CESC -0.068; TCGA COAD -0.092; TCGA HNSC -0.145; TCGA LUAD -0.071; TCGA LUSC -0.066; TCGA PRAD -0.129; TCGA SARC -0.055; TCGA STAD -0.069 |
hsa-miR-708-3p | CCNDBP1 | 9 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; PRAD; SARC; STAD | MirTarget | TCGA BLCA -0.052; TCGA BRCA -0.093; TCGA COAD -0.078; TCGA HNSC -0.09; TCGA LUAD -0.108; TCGA LUSC -0.085; TCGA PRAD -0.053; TCGA SARC -0.078; TCGA STAD -0.088 |
hsa-miR-708-3p | ATE1 | 9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PRAD; SARC | MirTarget | TCGA BLCA -0.112; TCGA COAD -0.106; TCGA ESCA -0.116; TCGA HNSC -0.217; TCGA KIRC -0.086; TCGA LGG -0.107; TCGA LUAD -0.081; TCGA PRAD -0.264; TCGA SARC -0.077 |
hsa-miR-708-3p | OPHN1 | 12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.062; TCGA BRCA -0.09; TCGA HNSC -0.099; TCGA KIRC -0.213; TCGA KIRP -0.098; TCGA LGG -0.137; TCGA LUAD -0.094; TCGA LUSC -0.064; TCGA PRAD -0.157; TCGA SARC -0.069; TCGA STAD -0.074; TCGA UCEC -0.084 |
hsa-miR-708-3p | NFAT5 | 9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD | mirMAP | TCGA BLCA -0.08; TCGA BRCA -0.058; TCGA CESC -0.067; TCGA HNSC -0.094; TCGA KIRC -0.123; TCGA KIRP -0.185; TCGA LUAD -0.097; TCGA LUSC -0.087; TCGA PRAD -0.146 |
hsa-miR-708-3p | CPEB4 | 12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC | mirMAP | TCGA BLCA -0.148; TCGA BRCA -0.091; TCGA CESC -0.09; TCGA HNSC -0.32; TCGA KIRC -0.092; TCGA LGG -0.104; TCGA LUAD -0.142; TCGA LUSC -0.244; TCGA PRAD -0.147; TCGA SARC -0.075; TCGA STAD -0.117; TCGA UCEC -0.107 |
hsa-miR-708-3p | PRKAR2A | 9 cancers: BLCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.099; TCGA CESC -0.153; TCGA ESCA -0.153; TCGA HNSC -0.318; TCGA LUAD -0.13; TCGA LUSC -0.062; TCGA PRAD -0.254; TCGA SARC -0.153; TCGA STAD -0.077 |
hsa-miR-708-3p | TMX4 | 10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; STAD | mirMAP | TCGA BLCA -0.098; TCGA CESC -0.11; TCGA ESCA -0.133; TCGA HNSC -0.18; TCGA KIRC -0.081; TCGA LUSC -0.177; TCGA PAAD -0.144; TCGA PRAD -0.164; TCGA SARC -0.105; TCGA STAD -0.071 |
hsa-miR-708-3p | RNF38 | 9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC | mirMAP | TCGA BLCA -0.111; TCGA BRCA -0.096; TCGA HNSC -0.092; TCGA KIRC -0.078; TCGA KIRP -0.065; TCGA LUAD -0.076; TCGA LUSC -0.054; TCGA PRAD -0.127; TCGA SARC -0.094 |
hsa-miR-708-3p | DUSP19 | 10 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD | mirMAP | TCGA BLCA -0.148; TCGA BRCA -0.059; TCGA KIRC -0.054; TCGA KIRP -0.057; TCGA LGG -0.125; TCGA LUAD -0.12; TCGA PRAD -0.301; TCGA SARC -0.099; TCGA THCA -0.116; TCGA STAD -0.085 |
hsa-miR-708-3p | LRRC2 | 10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.284; TCGA BRCA -0.205; TCGA ESCA -0.523; TCGA HNSC -0.701; TCGA KIRC -0.223; TCGA LUAD -0.263; TCGA LUSC -0.573; TCGA PAAD -0.245; TCGA PRAD -0.245; TCGA STAD -0.23 |
hsa-miR-708-3p | RAPH1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; UCEC | mirMAP | TCGA BLCA -0.081; TCGA CESC -0.07; TCGA COAD -0.073; TCGA ESCA -0.061; TCGA HNSC -0.132; TCGA KIRC -0.072; TCGA LUAD -0.076; TCGA LUSC -0.149; TCGA UCEC -0.229 |
hsa-miR-708-3p | KLHL15 | 10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LUAD; PAAD; PRAD; STAD | mirMAP | TCGA BLCA -0.088; TCGA BRCA -0.114; TCGA COAD -0.093; TCGA ESCA -0.077; TCGA KIRC -0.083; TCGA LGG -0.064; TCGA LUAD -0.078; TCGA PAAD -0.113; TCGA PRAD -0.182; TCGA STAD -0.072 |
hsa-miR-708-3p | EPM2AIP1 | 10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA | mirMAP | TCGA BLCA -0.071; TCGA BRCA -0.067; TCGA HNSC -0.077; TCGA KIRC -0.1; TCGA KIRP -0.121; TCGA LGG -0.069; TCGA LUAD -0.059; TCGA PAAD -0.082; TCGA PRAD -0.079; TCGA THCA -0.074 |
hsa-miR-708-3p | ZC3H6 | 9 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD | mirMAP | TCGA BLCA -0.08; TCGA BRCA -0.143; TCGA HNSC -0.09; TCGA KIRP -0.151; TCGA LGG -0.062; TCGA LUAD -0.094; TCGA LUSC -0.091; TCGA PAAD -0.088; TCGA PRAD -0.113 |
hsa-miR-708-3p | VPS13A | 10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; PAAD; SARC | mirMAP | TCGA BLCA -0.072; TCGA BRCA -0.104; TCGA CESC -0.075; TCGA COAD -0.101; TCGA ESCA -0.166; TCGA KIRC -0.077; TCGA KIRP -0.088; TCGA LUAD -0.054; TCGA PAAD -0.158; TCGA SARC -0.081 |
hsa-miR-708-3p | CHMP2B | 10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; STAD | miRNATAP | TCGA BLCA -0.078; TCGA CESC -0.087; TCGA COAD -0.072; TCGA ESCA -0.2; TCGA HNSC -0.097; TCGA KIRC -0.065; TCGA LUAD -0.077; TCGA LUSC -0.114; TCGA SARC -0.077; TCGA STAD -0.054 |
hsa-miR-708-3p | PAFAH2 | 13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC | MirTarget | TCGA BRCA -0.088; TCGA CESC -0.103; TCGA COAD -0.084; TCGA ESCA -0.242; TCGA HNSC -0.14; TCGA KIRC -0.098; TCGA KIRP -0.054; TCGA LUAD -0.091; TCGA LUSC -0.152; TCGA PRAD -0.081; TCGA THCA -0.095; TCGA STAD -0.083; TCGA UCEC -0.063 |
hsa-miR-708-3p | TMF1 | 11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; STAD | MirTarget | TCGA BRCA -0.051; TCGA CESC -0.177; TCGA COAD -0.084; TCGA ESCA -0.19; TCGA HNSC -0.165; TCGA KIRC -0.067; TCGA KIRP -0.125; TCGA LUAD -0.061; TCGA LUSC -0.161; TCGA PRAD -0.057; TCGA STAD -0.055 |
hsa-miR-708-3p | RALGPS1 | 9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUAD; PAAD; SARC; STAD | mirMAP | TCGA BRCA -0.121; TCGA ESCA -0.396; TCGA KIRC -0.279; TCGA KIRP -0.191; TCGA LGG -0.111; TCGA LUAD -0.086; TCGA PAAD -0.268; TCGA SARC -0.069; TCGA STAD -0.13 |
hsa-miR-708-3p | RBM47 | 9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD | mirMAP | TCGA BRCA -0.095; TCGA CESC -0.143; TCGA COAD -0.165; TCGA ESCA -0.394; TCGA HNSC -0.241; TCGA KIRC -0.14; TCGA LUAD -0.072; TCGA LUSC -0.167; TCGA PAAD -0.176 |
hsa-miR-708-3p | TMBIM6 | 9 cancers: CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD | MirTarget | TCGA CESC -0.069; TCGA COAD -0.104; TCGA ESCA -0.122; TCGA HNSC -0.088; TCGA LUAD -0.073; TCGA LUSC -0.095; TCGA PRAD -0.089; TCGA THCA -0.057; TCGA STAD -0.059 |
hsa-miR-708-3p | FGD4 | 9 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; STAD | MirTarget | TCGA CESC -0.155; TCGA COAD -0.124; TCGA ESCA -0.317; TCGA HNSC -0.153; TCGA KIRC -0.078; TCGA LUAD -0.213; TCGA LUSC -0.342; TCGA PRAD -0.242; TCGA STAD -0.093 |
hsa-miR-708-3p | BEND7 | 9 cancers: CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; STAD | mirMAP | TCGA CESC -0.524; TCGA ESCA -0.593; TCGA HNSC -0.21; TCGA KIRP -0.078; TCGA LGG -0.091; TCGA LUAD -0.171; TCGA LUSC -0.4; TCGA PAAD -0.211; TCGA STAD -0.156 |
hsa-miR-708-3p | ACOX1 | 9 cancers: COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; THCA; STAD | mirMAP | TCGA COAD -0.096; TCGA ESCA -0.199; TCGA HNSC -0.125; TCGA KIRC -0.065; TCGA LUAD -0.111; TCGA PAAD -0.161; TCGA PRAD -0.081; TCGA THCA -0.065; TCGA STAD -0.122 |
Enriched cancer pathways of putative targets